Regeneron Pharmaceuticals
REGNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations
Market cap
$93.411 B
$902.98 -2.98%
Close of 6 Nov 2026
As of 6 Nov 2026, Regeneron Pharmaceuticals (REGN) has a market capitalization of $93.4B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.
Revenue
$14.3B
#309 by revenue
Earnings
$4.50B
#108 by earnings
Shares outstanding
106,300,000
Latest filing cover page
P/E ratio
20.7
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations, ranked by market cap
All 498 →- #12SanofiSNY$114.3B
- #13GSKGSK$101.9B
- #14Regeneron PharmaceuticalsREGN$93.4B
- #15Takeda PharmaceuticalTAK$67.1B
- #16Teva Pharmaceutical IndustriesTEVA$48.7B
What if Regeneron Pharmaceuticals were worth as much as…
Open the what-if tool →Where these numbers come from
Share counts and financials for Regeneron Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.